Share
5 min read
Evidence-based

We ran our own APOE4 photobiomodulation study. Here's the data.

60+ carriers, 4 months: Real-world data is messy. We tracked all of it. Here's what moved.

T
· Reviewed by Dr. Kevin Tran, PharmD
Updated recently
We ran our own APOE4 photobiomodulation study. Here's the data.

Key takeaways · TL;DR

60+ carriers, 4 months: Real-world data is messy. We tracked all of it. Here's what moved.

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

What I'll show you on June 4
I'm presenting the full results live, alongside Neuronic's data analyst, who ran the formal statistics. Together we'll cover: What the data actually showed Where our methodology fell short — yes, I'll show you the cracks What these signals mean for designing better real-world prevention research No spin. No cherry-picking. The wins and the warts — because that's the only kind of science I'd trust with my own brain.
How our members got involved
When we launched this study, Phoenix members got the Neuronic device at a $695 discount (essentially the cost price of making the device) plus a 90-day satisfaction guarantee . Real device, real data, no risk. That's what being inside the community unlocks: not just access to studies like this, but access on terms you won't find anywhere else.
Want in on the next one?
This was one study. We're building a pipeline of them — APOE4-specific research you literally can't join anywhere else, because no one else has a community of carriers tracking their data together. If you want first access to the next study, join The Phoenix Community →
Keep reading

Related protocols.